| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Q32 Bio Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 70,687 | $948,620 | $13.42 | 24 Feb 2025 | Direct |
| Q32 Bio Inc. | Chief Medical Officer | Common Stock | 37,500 | $273,375 | $7.29 | 24 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| QTTB | Q32 Bio Inc. | 24 Feb 2025 | 7 | $0 | 4 | Chief Medical Officer | 26 Feb 2025, 21:57 |
| QTTB | Homology Medicines, Inc. | 25 Mar 2024 | 1 | $0 | 4 | Chief Medical Officer | 27 Mar 2024, 17:37 |
| QTTB | Homology Medicines, Inc. | 25 Mar 2024 | 0 | $0 | 3 | Chief Medical Officer | 27 Mar 2024, 17:20 |